| |
Wang X, Goh CH, and Li B (2007). p38 MAPK regulate osteoblast differentiation through osterix. Endocrinology 148(4):1629-1637.
Rasheed N#, Wang X#, Leong WF, Yeh J, and Li B (2006).
Atm deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoblastogenesis.
Human Molecular Genetics, 15(12): 1938-1948. #Equal contribution.
Wang X, Kua HY, Hu Y, Guo K, Zeng Q, Karsenty G, Yeh J, and Li B (2006).
p53 represses the expression of transcription factor osterix and functions as a negative regulator of osteoblastogenesis and bone formation.
J. Cell Biol., 172:115-125.
Zeng L, Hu Y, and Li B (2005). Identification of TopBP1 as a c-Abl interacting protein and a repressor for c-Abl expression.
J. Biol. Chem. 280: 29374-29380.
Hu Y, Wang X, Zeng L, Cai DY, Sabapathy K, Goff SP, Firpo EJ, and Li B (2005). ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip1 expression via the Akt-FOXO3a pathway: implication of p27kip1 in cell response to oxidative stress. Mol. Biol. Cell. 16:3705-3718.
Li B*, Wang X, Rasheed N, Hu Y, Boast S, Ishii T, Nakayama K, Nakayama KI, and
Goff SP (2004).Distinct roles of c-Abl and Atm in oxidative stress response are mediated by PKCd.
Genes and Development 18:1824-37, 2004.
Hu Y, Chan E, Wang X, Li B.
Activation of p38 MAPK is required for osteoblast differentiation.
Endocrinology 144:2068-2074, 2003
|
|